Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19601 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Andreas Glenthøj und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Registries, Pyruvate Kinase, Anemia, Hemolytic, Congenital Nonspherocytic, Pyruvate Metabolism, Inborn Errors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agios Pharmaceuticals, Inc., Agios Pharmaceuticals.
Abstract (Originalsprache)
Pyruvate kinase (PK) deficiency, a rare, congenital haemolytic anaemia caused by mutations in the PKLR gene, is associated with many clinical manifestations, but the full disease burden has yet to be characterised. The Peak Registry (NCT03481738) is an observational, longitudinal registry of adult and paediatric patients with PK deficiency. Here, we described comorbidities and complications in these patients by age at most recent visit and PKLR genotype. As of 13 May 2022, 241 patients were included in the analysis. In total, 48.3% had undergone splenectomy and 50.5% had received chelation therapy. History of iron overload (before enrolment/during follow‐up) was common (52.5%), even in never‐transfused patients (20.7%). Neonatal complications and symptoms included jaundice, splenomegaly and hepatomegaly, with treatment interventions required in 41.5%. Among adults, osteopenia/osteoporosis occurred in 19.0% and pulmonary hypertension in 6.7%, with median onset ages of 37, 33 and 22 years, respectively. Biliary events and bone health problems were common across PKLR genotypes. Among 11 patients who had thromboembolic events, eight had undergone prior splenectomy. Patients with PK deficiency may have many complications, which can occur early in and throughout life. Awareness of their high disease burden may help clinicians better provide appropriate monitoring and management of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
- Thrive with PK Deficiency, Bloomington, Minnesota, USA.
- Center for Benign Hematology, Thrombosis and Hemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, Palo Alto, California, USA.
- Division of Hematology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Andreas Glenthøj, Rachael F Grace, Eduard J van Beers, Kevin H M Kuo, Paola Bianchi
Förderung
- Agios Pharmaceuticals, Inc.
- Agios Pharmaceuticals
Zitieren
APA
Glenthøj, A., Grace, R. F., Lander, C., van Beers, E. J., Glader, B., Kuo, K. H. M., Yan, Y., McGee, B., Boscoe, A. N., Li, J., & Bianchi, P. (2024). Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry. British Journal of Haematology. https://doi.org/10.1111/bjh.19601
Vancouver
Glenthøj A, Grace RF, Lander C, van Beers EJ, Glader B, Kuo KHM, et al. Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry. British Journal of Haematology. 2024. doi:10.1111/bjh.19601
BibTeX
@article{Glenthj2024,
author = {Glenthøj, Andreas and Grace, Rachael F and Lander, Carl and van Beers, Eduard J and Glader, Bertil and Kuo, Kevin H M and Yan, Yan and McGee, Bryan and Boscoe, Audra N and Li, Junlong and Bianchi, Paola},
title = {Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19601}
}
EUVIMED